医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Pearl to Introduce Groundbreaking AI to Australian and New Zealand Dentistry

2021年10月14日 AM07:00
このエントリーをはてなブックマークに追加


 

LOS ANGELES

Pearl, the leader in AI solutions for efficiency, accuracy, and consistency in dental care, today announced that it has received authorization to introduce its Second Opinion® AI solution to the Australian and New Zealand dental markets. The clearances from Australia’s Therapeutic Goods Administration (TGA) and New Zealand’s Medical Devices Safety Authority (MEDSAFE) follow the European CE marking Second Opinion® received earlier this year for use as an assistive tool in dental radiology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211013006161/en/

Pearl today announced that it has received authorization to introduce its Second Opinion AI solution to the Australian and New Zealand dental markets. (Photo: Business Wire)

Pearl today announced that it has received authorization to introduce its Second Opinion AI solution to the Australian and New Zealand dental markets. (Photo: Business Wire)

The clearances announced today signal growing recognition of AI’s utility in clinical dentistry. Pearl – a driving force behind AI’s emergence in the dental category – developed Second Opinion® to aid dentists in their evaluation of patient x-rays. The tool applies radiologic computer vision to highlight potential areas of interest, giving dentists a second set of eyes when reading x-rays – both to help dentists ensure that patient care decisions are based on the strongest foundation possible and to give dentists a new level of assurance when communicating findings to patients.

“Patients in Australia and New Zealand will soon have the opportunity to experience AI during dental appointments and gain assurance that they are receiving the best diagnosis and treatment plan based on their individual needs,” said Ophir Tanz, CEO and founder of Pearl. “Our Second Opinion® technology enables dentists to perform their job more confidently, see more patients and ensure a higher standard of need-based care. All of these factors are driving growth and better patient outcomes in dentistry.”

Second Opinion® detects a comprehensive array of pathologies, existing restorations and natural anatomy in dental x-rays. The system analyzes the images upon capture, allowing dentists conducting exams to review Second Opinion® detections in real-time, as well as to add their own detections and remove any AI findings they consider unhelpful.

Practices in Australia and New Zealand can sign up here for early access to the software through Pearl’s Second Opinion® beta launch program.

About Pearl

Pearl is shaping the future of dental care by delivering AI and computer vision solutions that advance efficiency, accuracy, transparency and patient care. Founded in 2019 by Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms. For more information or to request a demonstration, please visit hellopearl.com/demo.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211013006161/en/

CONTACT

Alex Foley

Matter Health for Pearl

Pearl@matternow.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease